发明授权
US08017556B2 Crystalline form of [3-(4,5-dihydro-3-isoxazolyl)-2-methyl-4-(methylsulfonyl)phenyl]-(5-hydroxy-1-methyl-1H-pyrazol-4-yl)methanone
有权
[3-（4,5-二氢-3-异恶唑基）-2-甲基-4-（甲基磺酰基）苯基] - （5-羟基-1-甲基-1H-吡唑-4-基）甲酮的结晶形式
![Crystalline form of [3-(4,5-dihydro-3-isoxazolyl)-2-methyl-4-(methylsulfonyl)phenyl]-(5-hydroxy-1-methyl-1H-pyrazol-4-yl)methanone](/docs/US/2011-09-13/US08017556B2/abs.jpg.600x600.jpg)
- 专利标题： Crystalline form of [3-(4,5-dihydro-3-isoxazolyl)-2-methyl-4-(methylsulfonyl)phenyl]-(5-hydroxy-1-methyl-1H-pyrazol-4-yl)methanone
- 专利标题（中）： [3-（4,5-二氢-3-异恶唑基）-2-甲基-4-（甲基磺酰基）苯基] - （5-羟基-1-甲基-1H-吡唑-4-基）甲酮的结晶形式
-
申请号： US12667120申请日： 2008-07-04
-
公开(公告)号： US08017556B2公开(公告)日： 2011-09-13
- 发明人: Joachim Gebhardt , Peter Erk , Heidi Emilia Saxell , Thomas Kroehl , Matthias Bratz
- 申请人： Joachim Gebhardt , Peter Erk , Heidi Emilia Saxell , Thomas Kroehl , Matthias Bratz
- 申请人地址： DE Ludwigshafen
- 专利权人： BASF SE
- 当前专利权人： BASF SE
- 当前专利权人地址： DE Ludwigshafen
- 代理机构： Brinks Hofer Gilson & Lione
- 优先权： EP07111981 20070706
- 国际申请： PCT/EP2008/058712 WO 20080704
- 国际公布： WO2009/007329 WO 20090115
- 主分类号： A01N43/80
- IPC分类号： A01N43/80 ; A01P13/00 ; C07D413/10
![Crystalline form of [3-(4,5-dihydro-3-isoxazolyl)-2-methyl-4-(methylsulfonyl)phenyl]-(5-hydroxy-1-methyl-1H-pyrazol-4-yl)methanone](/abs-image/US/2011/09/13/US08017556B2/abs.jpg.150x150.jpg)
摘要：
The present invention relates to crystalline forms of [3-(4,5-dihydro-3-isoxazolyl)-2- methyl-4-(methylsulfonyl)phenyl]-(5-hydroxy-1-methyl-1 H-pyrazol-4-yl)methanone, which is also known under the common name topramezone. The invention also relates to a process for the preparation of these crystalline forms and formulations for plant protection which comprise one of these crystalline forms of topramezone.
公开/授权文献
信息查询
IPC分类:
